Literature DB >> 27126044

Durable coexistence of donor and recipient strains after fecal microbiota transplantation.

Simone S Li1, Ana Zhu2, Vladimir Benes3, Paul I Costea2, Rajna Hercog3, Falk Hildebrand2, Jaime Huerta-Cepas2, Max Nieuwdorp4, Jarkko Salojärvi5, Anita Y Voigt6, Georg Zeller2, Shinichi Sunagawa7, Willem M de Vos8, Peer Bork9.   

Abstract

Fecal microbiota transplantation (FMT) has shown efficacy in treating recurrent Clostridium difficile infection and is increasingly being applied to other gastrointestinal disorders, yet the fate of native and introduced microbial strains remains largely unknown. To quantify the extent of donor microbiota colonization, we monitored strain populations in fecal samples from a recent FMT study on metabolic syndrome patients using single-nucleotide variants in metagenomes. We found extensive coexistence of donor and recipient strains, persisting 3 months after treatment. Colonization success was greater for conspecific strains than for new species, the latter falling within fluctuation levels observed in healthy individuals over a similar time frame. Furthermore, same-donor recipients displayed varying degrees of microbiota transfer, indicating individual patterns of microbiome resistance and donor-recipient compatibilities.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2016        PMID: 27126044     DOI: 10.1126/science.aad8852

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  186 in total

1.  Our Microbiome: On the Challenges, Promises, and Hype.

Authors:  Sara Federici; Jotham Suez; Eran Elinav
Journal:  Results Probl Cell Differ       Date:  2020

Review 2.  Impact of occupational exposure on human microbiota.

Authors:  Peggy S Lai; David C Christiani
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-04

Review 3.  Evolutionary and ecological forces that shape the bacterial communities of the human gut.

Authors:  J S Messer; E R Liechty; O A Vogel; E B Chang
Journal:  Mucosal Immunol       Date:  2017-02-01       Impact factor: 7.313

4.  Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.

Authors:  Anna M Seekatz; Casey M Theriot; Krishna Rao; Yu-Ming Chang; Alison E Freeman; John Y Kao; Vincent B Young
Journal:  Anaerobe       Date:  2018-04-12       Impact factor: 3.331

Review 5.  Recipient factors in faecal microbiota transplantation: one stool does not fit all.

Authors:  Camille Danne; Nathalie Rolhion; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-04-27       Impact factor: 46.802

6.  Fecal microbiota transplantation-early steps on a long journey ahead.

Authors:  Alexander Khoruts
Journal:  Gut Microbes       Date:  2017-04-10

Review 7.  The resilience of the intestinal microbiota influences health and disease.

Authors:  Felix Sommer; Jacqueline Moltzau Anderson; Richa Bharti; Jeroen Raes; Philip Rosenstiel
Journal:  Nat Rev Microbiol       Date:  2017-06-19       Impact factor: 60.633

Review 8.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.

Authors:  Nathaniel Aviv Cohen; Nitsan Maharshak
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 9.  To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes.

Authors:  Jens Walter; María X Maldonado-Gómez; Inés Martínez
Journal:  Curr Opin Biotechnol       Date:  2017-09-13       Impact factor: 9.740

10.  Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.

Authors:  Joseph C Mudd; Jason M Brenchley
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.